Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Bace2 Transgenic Models and Beta-Amyloid Modulation Updated On: Jan. 19, 2025
Alzheimer's Disease Research Grant

Bace2 Transgenic Models and Beta-Amyloid Modulation

Principal Investigator

Philip Wong, PhD

The Johns Hopkins University

Baltimore, MD, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$200,000

Active Dates

April 01, 2001 - March 31, 2003

Grant ID

A2001033

Summary

Amyloid beta peptides are created by the activities of beta- and gamma-secretases, two enzymes that are required to cut amyloid precursor protein (APP). Two beta-secretases called BACE1 and BACE2 may be involved in the generation of the toxic amyloid beta proteins. Dr. Wong has bred mice that lack the BACE1 enzyme. He has found that neurons from the mice lacking BACE1 no longer produce amyloid beta peptides, and this suggests that BACE1 is the principal enzyme required to generate amyloid beta proteins. Studies from other laboratories also suggest that BACE2 may serve to limit the production of amyloid beta. To test this hypothesis, Dr. Wong is attempting to create mice that produce high amounts of normal and/or mutant BACE2 to determine if these genetic alterations curtail amyloid beta production in ways that are consistent with the hypothesis. BACE2 mice will also be bred with “AD” mice to determine if the accumulation of amyloid beta is curtailed by the production of high amounts of BACE2. If it is, this knowledge could pave the way for scientists to design and test drugs that increase the level of BACE2 activity in humans with AD.